TSI announces the launch of the Porous Tube Thermodi...
Novel coronavirus (2019-nCoV) is a concern around th...
Shoreview, MN—TSI Incorporated, the world leader in particle counting instruments, is excited to announce that it will be featuring its BioTrak® Real-Time Viable Particle Counter as part of the Germfree Mobile Adaptive Bioproduction Suite in booth 3961 at INTERPHEX, March 21-23, in New York, New York.
TSI will also display its FMS Monitoring Software designed for reliable and hassle-free integration of environmental monitoring data, including real-time viable particle counting. The mobile adaptive bioproduction suite represents a new approach to the design of controlled aseptic environments to adapt emerging biopharmaceutical production processes and facilities to meet evolving production and validation requirements within the industry. TSI participates as a recognized, valuable partner with its BioTrak Real-Time Viable Particle Counter as the most efficient environmental monitoring instrument available for aseptic manufacturing facilities.
The BioTrak Real-Time Viable Particle Counter provides reliable in-process environmental monitoring without human intervention. Three instruments in one, the BioTrak Particle Counter offers continuous ISO-compliant optical particle counting, real-time viable particle counting and microbial sample collection for speciation—designed to reduce costs and improve quality.
"We're honored that Germfree has extended to us this exciting opportunity to be a part of this innovative display," said Patrick Hutchins, TSI Global Product Manager. "It is the perfect venue for attendees to familiarize themselves with the most efficient, cost-saving solutions available on the market today, and for TSI to showcase our innovative technology."
"TSI's BioTrak Real-Time Viable Particle Counter is a next-generation technology that combines the power of efficient and effective viable particulate detection with the ultimate trending tools for improved process performance monitoring and trending," said Carol Houts, Director of Quality Germfree. "We are excited to have TSI as an exhibit partner to demonstrate advanced technological approaches to solving the biopharmaceutical industry's challenge to meet risk management and process improvement goals and objectives."
About TSI Incorporated
TSI Incorporated serves a global market by investigating, identifying and solving measurement problems. As an industry leader in the design and production of precision instruments, TSI partners with research institutions and customers around the world to set the standard for measurements relating to aerosol science, health and safety, indoor air quality, air flow, fluid dynamics and biohazard detection. With headquarters based in the U.S. and field offices throughout Europe and Asia, TSI has established a worldwide presence in the markets we serve. Every day, our dedicated employees turn research into reality.
For more information on TSI Incorporated, visit our website: www.tsi.com, check out our page on Facebook: www.facebook.com/TSIIncorporated, or follow us on Twitter: www.twitter.com/TSIIncorporated.
Germfree manufactures advanced cGMP-compliant mobile and modular bioproduction and biocontainment platforms. The company was established in 1962 to provide aseptic control and biosafety for institutions ranging from hospital pharmacies to high containment laboratories. Today, Germfree's BSL-3 labs are deployed globally to meet the rigorous demands of military and public health agencies.
This extensive experience has positioned Germfree to build cleanroom platforms, which exceed the engineering standards of traditional facilities. Our leading-edge fabrication technology, engineering teams and subject-matter experts are located at our 140,000 square-foot (13,000 square-meter) US manufacturing plant. For more information, visit www.germfree.com.